Skip to main content

Anika Therapeutics, Inc.

ANIK
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000898437

In the last 90 days, Anika Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 133 institutions reported holding it in 13F filings for Q2 2026, worth $179.0M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Anika Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
122
+9 vs. Q2 2024
Shares held
13.1M
+1.46M (+12.6%) vs. Q2 2024
Total value
$323.5M
+$28.9M (+9.8%) vs. Q2 2024
New holders
15
34 more added
Sold out
6
49 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ANIK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 122 institutions
Q1 2021: 146 institutionsQ2 2021: 139 institutionsQ3 2021: 131 institutionsQ4 2021: 127 institutionsQ1 2022: 119 institutionsQ2 2022: 126 institutionsQ3 2022: 123 institutionsQ4 2022: 125 institutionsQ1 2023: 121 institutionsQ2 2023: 117 institutionsQ3 2023: 117 institutionsQ4 2023: 117 institutionsQ1 2024: 120 institutionsQ2 2024: 114 institutionsQ3 2024: 122 institutionsQ4 2024: 109 institutionsQ1 2025: 108 institutionsQ2 2025: 104 institutionsQ3 2025: 117 institutionsQ4 2025: 126 institutionsQ1 2026: 130 institutionsQ2 2026: 133 institutions
Value heldQ3 2024: $323.5M
Q1 2021: $543.0MQ2 2021: $568.9MQ3 2021: $559.5MQ4 2021: $483.3MQ1 2022: $341.4MQ2 2022: $302.2MQ3 2022: $320.5MQ4 2022: $388.0MQ1 2023: $375.6MQ2 2023: $340.4MQ3 2023: $242.3MQ4 2023: $300.2MQ1 2024: $340.4MQ2 2024: $335.3MQ3 2024: $323.5MQ4 2024: $206.2MQ1 2025: $190.7MQ2 2025: $134.2MQ3 2025: $115.0MQ4 2025: $117.5MQ1 2026: $179.1MQ2 2026: $179.0M
Institutions holding ANIK and their total value by quarter
QuarterHoldersValue
Q2 2026133$179.0M
Q1 2026130$179.1M
Q4 2025126$117.5M
Q3 2025117$115.0M
Q2 2025104$134.2M
Q1 2025108$190.7M
Q4 2024109$206.2M
Q3 2024122$323.5M
Q2 2024114$335.3M
Q1 2024120$340.4M
Q4 2023117$300.2M
Q3 2023117$242.3M
Q2 2023117$340.4M
Q1 2023121$375.6M
Q4 2022125$388.0M
Q3 2022123$320.5M
Q2 2022126$302.2M
Q1 2022119$341.4M
Q4 2021127$483.3M
Q3 2021131$559.5M
Q2 2021139$568.9M
Q1 2021146$543.0M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Anika Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding ANIK in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Riverwater Partners LLC101,996$2.55M1.27%+86,037+539.1%Added
Arrowstreet Capital, Limited Partnership108,793$2.69M0.00%00.0%Unchanged
Segall Bryant & Hamill, LLC108,799$2.69M0.04%+1,794+1.7%Added
Northern Trust Corp123,310$3.05M0.00%−6,627−5.1%Reduced
Franklin Resources Inc133,410$3.38M0.00%−8,341−5.9%Reduced
Charles Schwab Investment Management Inc149,956$3.70M0.00%−188−0.1%Reduced
D. E. Shaw & Co., Inc.154,061$3.81M0.00%+1,138+0.7%Added
Stonepine Capital Management, LLC189,308$4.68M2.95%+23,911+14.5%Added
Meros Investment Management, LP237,295$5.86M2.65%+24,581+11.6%Added
Capital Management Corp290,350$7.17M1.27%−38,270−11.6%Reduced
Alta Fundamental Advisers LLC296,082$7.31M3.02%00.0%Unchanged
State Street Corp305,225$7.54M0.00%−7,667−2.5%Reduced
Geode Capital Management, LLC324,964$8.03M0.00%−16,104−4.7%Reduced
Acadian Asset Management LLC448,784$11.1M0.03%+5,840+1.3%Added
Morgan Stanley452,977$11.2M0.00%−49,011−9.8%Reduced
Boothbay Fund Management, LLC503,838$12.4M0.39%+1,888+0.4%Added
Renaissance Technologies LLC574,229$14.2M0.02%−24,000−4.0%Reduced
Dimensional Fund Advisors LP707,366$17.5M0.00%−41,918−5.6%Reduced
Vanguard Group Inc798,643$19.7M0.00%+8,507+1.1%Added
Caligan Partners LP1,435,130$35.4M11.24%−863−0.1%Reduced
BlackRock, Inc.1,764,607$43.6M0.00%+1,764,607New
Trigran Investments, Inc.2,124,460$52.5M5.74%−11,772−0.6%Reduced
Virtus Investment Advisers, Inc.0$00.00%−45,579−100.0%Sold out
Squarepoint Ops LLC0$00.00%−21,648−100.0%Sold out
Trexquant Investment LP0$00.00%−17,899−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−9,238−100.0%Sold out
STRS Ohio0$00.00%−4,000−100.0%Sold out
Lazard Asset Management LLC0$00.00%−1,730−100.0%Sold out
BlackRock Inc.––––Not filed